Malaria Cure?

After spending four years and $7,000,000, OSRD researchers half-hoped, half-believed that they had found a permanent cure for relapsing malaria (which plagues almost half the world's population). Its name: SN 13,276. Last week in Atlantic City, Squibb Institute's Dr. James A. Shannon released some promising facts about this newest member of the eight-aminoquinoline group (to which belongs Plasmochin, antimalarial drug developed by German scientists in 1926, later discarded as ineffective and too toxic).

The new drug is so powerful that a two-week course of treatments cures the disease permanently, thus making possible coordinated, community-wide drives to stamp out malaria.

Beginning where Atabrine and quinine leave off, SN 13,276 costs no more, stops chills & fever in jig time, will not discolor the skin or nauseate.

Although sanguine about the new cure, Shannon had two reservations: 1) its toxicity, which may cause anemia (probably only in dark-skinned races), has not yet been determined; 2) SN 13,276 has been tried out on less than a hundred patients, may pan out poorly in large-scale tests.

This file is automatically generated by a robot program, so reader's discretion is required.